PTGIR and neoplasm: This released PGI2 binds to the PGI2 receptor (PTGIR) on ascitic TAMs, promoting their polarization toward an immunosuppressive and pro-tumor phenotype characterized by reduced phagocytic capacity; furthermore, secretion of immune-stimulated cytokines is diminished (86).